PROCTER & GAMBLE HEALTH | AJANTA PHARMA | PROCTER & GAMBLE HEALTH/ AJANTA PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 35.2 | 35.9 | 97.8% | View Chart |
P/BV | x | 10.7 | 7.8 | 137.4% | View Chart |
Dividend Yield | % | 2.0 | 0.3 | 593.5% |
PROCTER & GAMBLE HEALTH AJANTA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
AJANTA PHARMA Mar-23 |
PROCTER & GAMBLE HEALTH/ AJANTA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 1,426 | 376.3% | |
Low | Rs | 3,883 | 1,062 | 365.6% | |
Sales per share (Unadj.) | Rs | 740.7 | 297.2 | 249.2% | |
Earnings per share (Unadj.) | Rs | 138.2 | 46.7 | 296.0% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 57.1 | 271.8% | |
Dividends per share (Unadj.) | Rs | 95.00 | 7.00 | 1,357.1% | |
Avg Dividend yield | % | 2.1 | 0.6 | 365.1% | |
Book value per share (Unadj.) | Rs | 447.6 | 269.1 | 166.4% | |
Shares outstanding (eoy) | m | 16.60 | 125.91 | 13.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 4.2 | 149.2% | |
Avg P/E ratio | x | 33.5 | 26.6 | 125.6% | |
P/CF ratio (eoy) | x | 29.8 | 21.8 | 136.8% | |
Price / Book Value ratio | x | 10.3 | 4.6 | 223.4% | |
Dividend payout | % | 68.7 | 15.0 | 458.4% | |
Avg Mkt Cap | Rs m | 76,761 | 156,638 | 49.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 7,851 | 26.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 37,426 | 32.9% | |
Other income | Rs m | 184 | 986 | 18.6% | |
Total revenues | Rs m | 12,480 | 38,413 | 32.5% | |
Gross profit | Rs m | 3,247 | 7,833 | 41.5% | |
Depreciation | Rs m | 281 | 1,308 | 21.5% | |
Interest | Rs m | 8 | 58 | 13.2% | |
Profit before tax | Rs m | 3,142 | 7,453 | 42.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 1,573 | 53.9% | |
Profit after tax | Rs m | 2,295 | 5,880 | 39.0% | |
Gross profit margin | % | 26.4 | 20.9 | 126.2% | |
Effective tax rate | % | 27.0 | 21.1 | 127.8% | |
Net profit margin | % | 18.7 | 15.7 | 118.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 28,252 | 41.5% | |
Current liabilities | Rs m | 6,791 | 11,393 | 59.6% | |
Net working cap to sales | % | 40.0 | 45.0 | 88.9% | |
Current ratio | x | 1.7 | 2.5 | 69.6% | |
Inventory Days | Days | 263 | 66 | 399.2% | |
Debtors Days | Days | 343 | 10 | 3,332.3% | |
Net fixed assets | Rs m | 10,617 | 18,707 | 56.8% | |
Share capital | Rs m | 166 | 253 | 65.7% | |
"Free" reserves | Rs m | 7,265 | 33,624 | 21.6% | |
Net worth | Rs m | 7,431 | 33,877 | 21.9% | |
Long term debt | Rs m | 0 | 13 | 0.0% | |
Total assets | Rs m | 22,330 | 47,047 | 47.5% | |
Interest coverage | x | 409.1 | 128.6 | 318.1% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.8 | 69.2% | |
Return on assets | % | 10.3 | 12.6 | 81.7% | |
Return on equity | % | 30.9 | 17.4 | 177.9% | |
Return on capital | % | 42.4 | 22.2 | 191.3% | |
Exports to sales | % | 0 | 59.9 | 0.0% | |
Imports to sales | % | 13.1 | 11.5 | 113.8% | |
Exports (fob) | Rs m | NA | 22,420 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 4,293 | 37.4% | |
Fx inflow | Rs m | 1,465 | 22,420 | 6.5% | |
Fx outflow | Rs m | 1,605 | 4,293 | 37.4% | |
Net fx | Rs m | -140 | 18,127 | -0.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 7,918 | 29.8% | |
From Investments | Rs m | -215 | -5,596 | 3.8% | |
From Financial Activity | Rs m | -985 | -1,079 | 91.3% | |
Net Cashflow | Rs m | 1,160 | 1,243 | 93.3% |
Indian Promoters | % | 0.0 | 66.2 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 26.0 | 76.7% | |
FIIs | % | 6.2 | 8.5 | 73.1% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 33.8 | 142.6% | |
Shareholders | 56,778 | 55,488 | 102.3% | ||
Pledged promoter(s) holding | % | 0.0 | 12.3 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | AJANTA PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 2.12% | 0.42% | -0.15% |
1-Month | 0.43% | -5.41% | 0.49% |
1-Year | 2.20% | 63.35% | 52.81% |
3-Year CAGR | -8.80% | 20.80% | 14.20% |
5-Year CAGR | 4.98% | 25.17% | 19.23% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the AJANTA PHARMA share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of AJANTA PHARMA the stake stands at 66.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of AJANTA PHARMA.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
AJANTA PHARMA paid Rs 7.0, and its dividend payout ratio stood at 15.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of AJANTA PHARMA.
For a sector overview, read our pharmaceuticals sector report.
Asian markets traded higher on Tuesday following overnight gain on Wall Street.